Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Vascular Surgery
Published in: Annals of Vascular Surgery 2/2006

01-03-2006

Acute Leg Ischemia: The Dark Side of a Percutaneous Femoral Artery Closure Device

Authors: Jan Wille, MD, PhD, Jan Albert Vos, MD, Tim T.C. Overtoom, MD, Maarten J. Suttorp, MD, PhD, Eric D. W. M. van de Pavoordt, MD, PhD, Jean-Paul P. M. de Vries, MD, PhD

Published in: Annals of Vascular Surgery | Issue 2/2006

Login to get access

Abstract

The use of femoral artery closure devices to obtain hemostasis after percutaneous catheterization has become widespread because of their proven feasibility in combination with patient-related advantages. Since 2002 more than 6,500 patients have undergone either diagnostic angiography or therapeutic intervention via the femoral route with an Angioseal closure device in our hospital. We were faced with six cases of limb-threatening complications, which are described here. Most (5/6) complications were of obstructive origin due to traumatic dissection or occlusion of the artery mainly caused by malpositioning of the device. Recommendations are made in order to prevent or successfully overcome this certainly increasing problem in the vascular field.
Literature
1.
Aker UT, Kensey KR, Heuser RR, Sandza JG, Kussmaul WG III. Immediate arterial hemostasis after cardiac catheterization: initial experience with a new puncture closure device. Cathet Cardiovasc Diagn 1994;31:228–232PubMedCrossRef
2.
Kussmaul WG III, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685–1692PubMedCrossRef
3.
Resnic FS, Blake GJ, Ohno-Machado L, et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol 2001;88:493–496PubMedCrossRef
4.
Sanborn TA, Biggs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273–1279PubMedCrossRef
5.
Heintzen MP, Straure BE. Peripheral arterial complications after heart catheterization. Herz 1998;23:4–20PubMed
6.
Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization. J A M A 2004;291:350–357PubMedCrossRef
7.
Carey D, Martin JR, Moore CA, Valentine MC, Nygaard ThW. Complications of femoral artery closure devices. Cathet Cardiovasc Intervent 2001;52:3–7CrossRef
8.
Lumdsen AB, Miller JM, Kosinski AS, et al. A prospective evaluation of surgically treated groin complications following percutaneous cardiac procedures. Am Surg 1994;60:132–137
9.
Henry M, Amor M, Allaoui M, Tricoche O. A new access site management tool: the Angioseal hemostatic puncture closure device. J Endovasc Surg 1995;2:289–296PubMedCrossRef
10.
Cremonesi A, Castriota F, Tarantino F, et al. Femoral arterial hemostasis using the Angioseal system after coronary and vascular percutaneous angioplasty and stenting. J Invas Cardiol 1998;10:464–469
11.
Shammas NW, Rajendran VR, Alldredge SG, et al. Randomized comparison of vasoseal and angioseal closure devices in patients undergoing coronary angiography and angioplasty. Catheter Cardiovasc Interv 2002;55:421–425PubMedCrossRef
12.
Abando A, Hood D, Weaver F, Katz S. The use of the Angioseal device for femoral artery closure. J Vasc Surg 2004;40:287–290PubMedCrossRef
13.
Shaw JA, Gravereaux EC, Winters GL, Eisenhauer AC. An unusual cause of claudication. Catheter Cardiovasc Interv 2003;60:562–565PubMedCrossRef
14.
Sprouse LR, Botta DM, Hamilton IN. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J Vasc Surg 2001;33:688–693PubMedCrossRef
Metadata
Title
Acute Leg Ischemia: The Dark Side of a Percutaneous Femoral Artery Closure Device
Authors
Jan Wille, MD, PhD
Jan Albert Vos, MD
Tim T.C. Overtoom, MD
Maarten J. Suttorp, MD, PhD
Eric D. W. M. van de Pavoordt, MD, PhD
Jean-Paul P. M. de Vries, MD, PhD
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Annals of Vascular Surgery / Issue 2/2006
Print ISSN: 0890-5096
Electronic ISSN: 1615-5947
DOI
https://doi.org/10.1007/s10016-006-9005-3

Other articles of this Issue 2/2006

Annals of Vascular Surgery 2/2006 Go to the issue

OriginalPaper

Endovascular Thoracic Aortic Repair and Previous or Concomitant Abdominal Aortic Repair: Is the Increased Risk of Spinal Cord Ischemia Real?

OriginalPaper

Factors Affecting Perioperative Mortality and Wound-Related Complications Following Major Lower Extremity Amputations

Basic Science Research

Localized Administration of Doxycycline Suppresses Aortic Dilatation in an Experimental Mouse Model of Abdominal Aortic Aneurysm

Report

Novel Endovascular Treatment of Blunt Thoracic Aortic Trauma with a Self-Expanding Stent Lined with Aortic Extender Cuffs

Correspondence

Nonpenetrating Clips for End-to-End Anastomosis of Arteries and Veins under Growing Conditions

Report

Lemierre’s Syndrome in a Patient with Antiphospholipid Syndrome